Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Quinti

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Human Molecular Genetics|July 28, 2011
The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNSMichele M Maxwell, Elizabeth M Tomkinson, Johnathan Nobles, et al.
Scientific Reports|January 20, 2018
Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial PhagocytosisCan Zhang, Ana Griciuc, Eloise Hudry, et al.
Circulation|April 11, 2007
Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensorFarouc A Jaffer, Dong-Eog Kim, Luisa Quinti, et al.
Plos Currents|September 30, 2010
Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell modelLuisa Quinti, Vanita Chopra, Dante Rotili, et al.
Frontiers in Pharmacology|August 21, 2023
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's diseaseBen Boyarko, Sonia Podvin, Barry Greenberg, et al.
Journal of Alzheimer'S Disease : JAD|February 13, 2021
Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's DiseaseTimothy M Shoup, Ana Griciuc, Marc D Normandin, et al.
Cell Reports|December 4, 2012
The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse modelsVanita Chopra, Luisa Quinti, Jinho Kim, et al.
Neuron|September 9, 2023
Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signalingEunhee Kim, Hyeonwoo Kim, Mark P Jedrychowski, et al.
Plos One|January 22, 2015
The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemiaXiqun Chen, Pauline Wales, Luisa Quinti, et al.
Neuron|October 18, 2025
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease by impairing microglial functionDominika J Pilat, Hoang Le, Dmitry Prokopenko, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Human Molecular Genetics|July 28, 2011
The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNSMichele M Maxwell, Elizabeth M Tomkinson, Johnathan Nobles, et al.
Scientific Reports|January 20, 2018
Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial PhagocytosisCan Zhang, Ana Griciuc, Eloise Hudry, et al.
Circulation|April 11, 2007
Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensorFarouc A Jaffer, Dong-Eog Kim, Luisa Quinti, et al.
Plos Currents|September 30, 2010
Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell modelLuisa Quinti, Vanita Chopra, Dante Rotili, et al.
Frontiers in Pharmacology|August 21, 2023
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's diseaseBen Boyarko, Sonia Podvin, Barry Greenberg, et al.
Journal of Alzheimer'S Disease : JAD|February 13, 2021
Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's DiseaseTimothy M Shoup, Ana Griciuc, Marc D Normandin, et al.
Cell Reports|December 4, 2012
The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse modelsVanita Chopra, Luisa Quinti, Jinho Kim, et al.
Neuron|September 9, 2023
Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signalingEunhee Kim, Hyeonwoo Kim, Mark P Jedrychowski, et al.
Plos One|January 22, 2015
The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemiaXiqun Chen, Pauline Wales, Luisa Quinti, et al.
Neuron|October 18, 2025
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease by impairing microglial functionDominika J Pilat, Hoang Le, Dmitry Prokopenko, et al.
Pageof 3